Biology of Blood and Marrow Transplantation
Volume 15, Issue 12 , Pages 1543-1554 , December 2009

Race and Socioeconomic Status Influence Outcomes of Unrelated Donor Hematopoietic Cell Transplantation

  • K. Scott Baker

      Affiliations

    • Fred Hutchinson Cancer Research Center, Seattle, Washington
    • Corresponding Author InformationCorrespondence and reprint requests: K. Scott Baker, MD, MS, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, Mailstop D5-280, Seattle, WA 98109.
    • ,
  • Stella M. Davies

      Affiliations

    • Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
    • ,
  • Navneet S. Majhail

      Affiliations

    • University of Minnesota, Minneapolis, Minnesota
    • Center for International Blood and Marrow Transplant Research, Minneapolis, Minnesota
    • ,
  • Anna Hassebroek

      Affiliations

    • Center for International Blood and Marrow Transplant Research, Minneapolis, Minnesota
    • ,
  • John P. Klein

      Affiliations

    • Center for International Blood and Marrow Transplant Research, Milwaukee, Wisconsin
    • ,
  • Karen K. Ballen

      Affiliations

    • Massachusetts General Hospital, Boston, Massachusetts
    • ,
  • Carolyn L. Bigelow

      Affiliations

    • University of Mississippi Medical Center, Jackson, Mississippi
    • ,
  • Haydar A. Frangoul

      Affiliations

    • Vanderbilt University Medical Center, Nashville, Tennessee
    • ,
  • Cheryl L. Hardy

      Affiliations

    • University of Mississippi Medical Center, Jackson, Mississippi
    • ,
  • Christopher Bredeson

      Affiliations

    • Medical College of Wisconsin, Milwaukee, Wisconsin
    • ,
  • Jason Dehn

      Affiliations

    • National Marrow Donor Program, Minneapolis, Minnesota
    • ,
  • Debra Friedman

      Affiliations

    • Vanderbilt University Medical Center, Nashville, Tennessee
    • ,
  • Theresa Hahn

      Affiliations

    • Roswell Park Cancer Institute, Buffalo, New York
    • ,
  • Gregory Hale

      Affiliations

    • All Children's Hospital, Saint Petersburg, FL
    • ,
  • Hillard M. Lazarus

      Affiliations

    • University Hospitals Case Medical Center, Cleveland, Ohio
    • ,
  • C.F. LeMaistre

      Affiliations

    • Texas Transplant Institute, San Antonio, Texas
    • ,
  • Fausto Loberiza

      Affiliations

    • University of Nebraska Medical Center, Omaha, Nebraska
    • ,
  • Dipnarine Maharaj

      Affiliations

    • South Florida Bone Marrow/Stem Cell Transplant Institute, Boynton Beach, Florida
    • ,
  • Philip McCarthy

      Affiliations

    • Roswell Park Cancer Institute, Buffalo, New York
    • ,
  • Michelle Setterholm

      Affiliations

    • National Marrow Donor Program, Minneapolis, Minnesota
    • ,
  • Stephen Spellman

      Affiliations

    • National Marrow Donor Program, Minneapolis, Minnesota
    • ,
  • Michael Trigg

      Affiliations

    • Merck & Co. Inc., Wilmington, Delaware
    • ,
  • Richard T. Maziarz

      Affiliations

    • Oregon Health & Science University, Portland, Oregon
    • ,
  • Galen Switzer

      Affiliations

    • University of Pittsburgh, Pittsburgh, Pennsylvania
    • ,
  • Stephanie J. Lee

      Affiliations

    • Fred Hutchinson Cancer Research Center, Seattle, Washington
    • ,
  • J. Douglas Rizzo

      Affiliations

    • Center for International Blood and Marrow Transplant Research, Milwaukee, Wisconsin

Received 20 May 2009 ,Accepted 27 July 2009.

References 

  1. Asbell SO, Vijayakumar S. Racial differences in prostate-specific antigen levels in patients with local-regional prostate cancer. Prostate. 1997;31:42–46
  2. Iselin CE, Box JW, Vollmer RT, Layfield LJ, Robertson JE, Paulson DF. Surgical control of clinically localized prostate carcinoma is equivalent in African-American and white males. Cancer. 1998;83:2353–2360
  3. Kim JA, Kuban DA, el-Mahdi AM, Schellhammer PF. Carcinoma of the prostate: race as a prognostic indicator in definitive radiation therapy. Radiology. 1995;194:545–549
  4. Mayberry RM, Coates RJ, Hill HA, et al. Determinants of black/white differences in colon cancer survival. J Natl Cancer Inst. 1995;87:1686–1693
  5. Arbes SJ, Slade GD. Racial differences in stage at diagnosis of screenable oral cancers in North Carolina. J Public Health Dent. 1996;56:352–354
  6. Rubnitz JE, Lensing S, Razzouk BI, Pounds S, Pui CH, Ribeiro RC. Effect of race on outcome of white and black children with acute myeloid leukemia: the St. Jude experience. Pediatr Blood Cancer. 2007;48:10–15
  7. Metzger ML, Castellino SM, Hudson MM, et al. Effect of race on the outcome of pediatric patients with Hodgkin's lymphoma. J Clin Oncol. 2008;26:1282–1288
  8. Bain RP, Greenberg RS, Whitaker JP. Racial differences in survival of women with breast cancer. J Chronic Dis. 1986;39:631–642
  9. Moul JW, Douglas TH, McCarthy WF, McLeod DG. Black race is an adverse prognostic factor for prostate cancer recurrence following radical prostatectomy in an equal access health care setting. J Urol. 1996;155:1667–1673
  10. Lannin DR, Mathews HF, Mitchell J, Swanson MS, Swanson FH, Edwards MS. Influence of socioeconomic and cultural factors on racial differences in late-stage presentation of breast cancer. JAMA. 1998;279:1801–1807
  11. Franzini L, Williams AF, Franklin J, Singletary SE, Theriault RL. Effects of race and socioeconomic status on survival of 1,332 black, Hispanic, and white women with breast cancer. Ann Surg Oncol. 1997;4:111–118
  12. Serna DS, Lee SJ, Zhang MJ, et al. Trends in survival rates after allogeneic hematopoietic stem-cell transplantation for acute and chronic leukemia by ethnicity in the United States and Canada. J Clin Oncol. 2003;21:3754–3760
  13. Baker KS, Loberiza FR, Yu H, et al. Outcome of ethnic minorities with acute or chronic leukemia treated with hematopoietic stem-cell transplantation in the United States. J Clin Oncol. 2005;23:7032–7042
  14. Mielcarek M, Gooley T, Martin PJ, et al. Effects of race on survival after stem cell transplantation. Biol Blood Marrow Transplant. 2005;11:231–239
  15. Cavet J, Middleton PG, Segall M, Noreen H, Davies SM, Dickinson AM. Recipient tumor necrosis factor-alpha and interleukin-10 gene polymorphisms associate with early mortality and acute graft-versus-host disease severity in HLA-matched sibling bone marrow transplants. Blood. 1999;94:3941–3946
  16. Dickinson AM, Harrold JL, Cullup H. Haematopoietic stem cell transplantation: can our genes predict clinical outcome?. Expert Rev Mol Med. 2007;9:1–19
  17. Oh H, Loberiza FR, Zhang MJ, et al. Comparison of graft-versus-host-disease and survival after HLA-identical sibling bone marrow transplantation in ethnic populations. Blood. 2005;105:1408–1416
  18. Sinnott R. Virtues of the Haversine. Sky Telescope. 1984;159
  19. Zip-Codes.com. Zip Code Database-Deluxe Database specifications.
  20. Farag SS, Eapen M, Hurley C, et al. KIR Study Group, Center for International Blood and Marrow Transplantation Research. The effect of KIR ligand incompatibility on the outcome of unrelated donor transplants: a report from the Center for International Blood and Marrow Transplant Research, the European Blood and Marrow Transplant Registry and the Dutch Registry. Biol Blood Marrow Transplant. 2006;12:876–884
  21. Clark TG, Altman DG, De Stavola BL. Quantification of the completeness of follow-up. Lancet. 2002;359:1309–1310
  22. Przepiorka D, Weisdorf D, Martin P, et al. 1994 Consensus conference on acute GVHD grading. Bone Marrow Transplant. 1995;15:825–828
  23. Sullivan KM, Agura E, Anasetti C, et al. Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin Hematol. 1991;28:250–259
  24. Ringden O, Pavletic SZ, Anasetti C, et al. The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation. Blood. 2009;113:3110–3118
  25. Weisdorf D, Spellman S, Haagenson M, et al. Classification of HLA-matching for retrospective analysis of unrelated donor transplantation: revised definitions to predict survival. Biol Blood Marrow Transplant. 2008;14:748–758
  26. Szydlo R, Goldman JM, Klein JP, et al. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. J Clin Oncol. 1997;15:1767–1777
  27. Pasquini M, Wang Z. CIBMTR summary slides—2007 (Part 2). CIBMTR Newslett. 2008;14:6–13
  28. Klein JaW JT. Discretizing a continuous covariate in survival studies. In: Handbook of Statistics. Advances in Survival Analysis, Vol. 25. New York: Elsevier Science; 2004;
  29. Andersen CA. Score tests of homogeneity for survival data. Lifetime Data Anal. 1:145–156.
  30. Lohmueller KE, Indap AR, Schmidt S, et al. Proportionally more deleterious genetic variation in European than in African populations. Nature. 2008;451:994–997
  31. Kim DH, Park JY, Sohn SK, Lee NY, Suh JS, Lee KB. The association between multidrug resistance-1 gene polymorphisms and outcomes of allogeneic HLA-identical stem cell transplantation. Haematologica. 2006;91:848–851
  32. Chesney RW, Wyatt RJ. Racial disparities in renal transplantation in children. Pediatrics. 2003;112:409–411
  33. Nair S, Eustace J, Thuluvath PJ. Effect of race on outcome of orthotopic liver transplantation: a cohort study. Lancet. 2002;359:287–293
  34. McDonald GB, Slattery JT, Bouvier ME, et al. Cyclophosphamide metabolism, liver toxicity, and mortality following hematopoietic stem cell transplantation. Blood. 2003;101:2043–2048
  35. Robien K, Schubert MM, Bruemmer B, Lloid ME, Potter JD, Ulrich CM. Predictors of oral mucositis in patients receiving hematopoietic cell transplants for chronic myelogenous leukemia. J Clin Oncol. 2004;22:1268–1275
  36. Srivastava A, Poonkuzhali B, Shaji RV, et al. Glutathione S-transferase M1 polymorphism: a risk factor for hepatic venoocclusive disease in bone marrow transplantation. Blood. 2004;104:1574–1577
  37. Robien K, Bigler J, Yasui Y, et al. Methylenetetrahydrofolate reductase and thymidylate synthase genotypes and risk of acute graft-versus-host disease following hematopoietic cell transplantation for chronic myelogenous leukemia. Biol Blood Marrow Transplant. 2006;12:973–980
  38. McCune JS, Batchelder A, Deeg HJ, et al. Cyclophosphamide following targeted oral busulfan as conditioning for hematopoietic cell transplantation: pharmacokinetics, liver toxicity, and mortality. Biol Blood Marrow Transplant. 2007;13:853–862
  39. Suarez-Kurtz G, Pena SD. Pharmacogenomics in the Americas: the impact of genetic admixture. Curr Drug Targets. 2006;7:1649–1658
  40. Spielman RS, Bastone LA, Burdick JT, Morley M, Ewens WJ, Cheung VG. Common genetic variants account for differences in gene expression among ethnic groups. Nat Genet. 2007;39:226–231
  41. Zhang W, Duan S, Kistner EO, et al. Evaluation of genetic variation contributing to differences in gene expression between populations. Am J Hum Genet. 2008;82:631–640
  42. Popescu I, Vaughan-Sarrazin MS, Rosenthal GE. Differences in mortality and use of revascularization in black and white patients with acute MI admitted to hospitals with and without revascularization services. JAMA. 2007;297:2489–2495
  43. Stafford RS, Saglam D, Blumenthal D. National patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure. Arch Intern Med. 1997;157:2460–2464
  44. Ayanian JZ, Weissman JS, Chasan-Taber S, Epstein AM. Quality of care by race and gender for congestive heart failure and pneumonia. Med Care. 1999;37:1260–1269
  45. Kahn KL, Pearson ML, Harrison ER, et al. Health care for black and poor hospitalized Medicare patients. JAMA. 1994;271:1169–1174
  46. Rathore SS, Foody JM, Wang Y, et al. Race, quality of care, and outcomes of elderly patients hospitalized with heart failure. JAMA. 2003;289:2517–2524
  47. Winkleby MA, Kraemer HC, Ahn DK, Varady AN. Ethnic and socioeconomic differences in cardiovascular disease risk factors: findings for women from the Third National Health and Nutrition Examination Survey, 1988-1994. JAMA. 1998;280:356–362
  48. Zell JA, Cinar P, Mobasher M, Ziogas A, Meyskens FL, Anton-Culver H. Survival for patients with invasive cutaneous melanoma among ethnic groups: the effects of socioeconomic status and treatment. J Clin Oncol. 2008;26:66–75
  49. Zell JA, Rhee JM, Ziogas A, Lipkin SM, Anton-Culver H. Race, socioeconomic status, treatment, and survival time among pancreatic cancer cases in California. Cancer Epidemiol Biomarkers Prev. 2007;16:546–552
  50. Mackillop WJ, Zhang-Salomons J, Groome PA, Paszat L, Holowaty E. Socioeconomic status and cancer survival in Ontario. J Clin Oncol. 1997;15:1680–1689
  51. Yoo HY, Thuluvath PJ. Outcome of liver transplantation in adult recipients: influence of neighborhood income, education, and insurance. Liver Transpl. 2004;10:235–243
  52. SEER Cancer Statistics Review 1975-2006. Available at: http://www.seer.cancer.gov/csr/1975_2006/browse_csr.php?section=13&page=sect_13_table.07.htmlAccessed July 21, 2009

 Financial disclosure: See Acknowledgments on page 1552.

PII: S1083-8791(09)00364-4

doi: 10.1016/j.bbmt.2009.07.023

Biology of Blood and Marrow Transplantation
Volume 15, Issue 12 , Pages 1543-1554 , December 2009

Article Tools

* Image Usage & Resolution